Experimental Study on the Effects of Antihepatocarcinoma with Hydroxyapatite Nanoparticles in vitro

曹献英,戴红莲,贾莉,王红晖,闫玉华,李世普
DOI: https://doi.org/10.3969/j.issn.1671-170X.2002.05.011
2002-01-01
Abstract:[Purpose] To investigate the selective effect of hydroxyapatite (HAP) on hepatocarcinoma cells and hepatocyte. [Methods] Research target with cell line Bel-7402 human hepatoma cells and primary rat hepatocyte cells, growth state of cells were observed by inverted microscope, and growth curve were drawed with living cell counting method. [Results]The number of Bel-7402 cells treated by HAP nanoparticles was obviously fewer than control group(P 0.01), and there was a lot of vacuoles in cytoplasm of Bel-7402 cells. However, the number of survival hepatocyte cells treated by HAP nanoparticles of different concentration were increasing, and had no significant difference than control group. [Conclusion]HAP nanoparticles can inhibit hepatocarcinoma cells in vitro, but have little effect on normal hepatic cells.
What problem does this paper attempt to address?